LOC643677 Inhibitors
The protein "coiled-coil domain containing 168," abbreviated as CCDC168, is characterized by having a coiled-coil domain, which is a structural motif that stabilizes protein-protein interactions. The coiled-coil domain is a superhelical structure formed by two or more alpha-helices wound around each other, resembling the strands of a rope. This motif is commonly found in proteins that are involved in a variety of cellular processes, including vesicle transport, cell division, and the maintenance of cellular structure.Proteins with coiled-coil domains, such as CCDC168, often function as part of larger protein complexes. The coiled-coil regions can facilitate the formation of these complexes by providing a structural framework for the interaction between different protein subunits. This capability makes CCDC168 potentially significant in the assembly or function of multi-protein structures within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor, potentially affecting various signaling pathways that might be relevant to C13orf40. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which could impact protein synthesis and cell growth pathways, potentially influencing C13orf40 function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, which could affect protein degradation pathways, possibly relevant to C13orf40. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially impacting signaling pathways that could intersect with C13orf40-related processes. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
An antimetabolite that inhibits thymidylate synthase, potentially affecting DNA synthesis and repair mechanisms that could be relevant to C13orf40. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that inhibits calcineurin, potentially impacting signaling pathways relevant to C13orf40. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor, affecting calcium homeostasis, which might influence C13orf40-related processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MAP kinase kinase (MEK), potentially affecting signaling pathways related to C13orf40. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting cytoskeletal dynamics, which might be relevant to C13orf40. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor, potentially influencing apoptotic pathways indirectly related to C13orf40. | ||||||